CBLUE: A Chinese Biomedical Language Understanding Evaluation Benchmark
read the original abstract
Artificial Intelligence (AI), along with the recent progress in biomedical language understanding, is gradually changing medical practice. With the development of biomedical language understanding benchmarks, AI applications are widely used in the medical field. However, most benchmarks are limited to English, which makes it challenging to replicate many of the successes in English for other languages. To facilitate research in this direction, we collect real-world biomedical data and present the first Chinese Biomedical Language Understanding Evaluation (CBLUE) benchmark: a collection of natural language understanding tasks including named entity recognition, information extraction, clinical diagnosis normalization, single-sentence/sentence-pair classification, and an associated online platform for model evaluation, comparison, and analysis. To establish evaluation on these tasks, we report empirical results with the current 11 pre-trained Chinese models, and experimental results show that state-of-the-art neural models perform by far worse than the human ceiling. Our benchmark is released at \url{https://tianchi.aliyun.com/dataset/dataDetail?dataId=95414&lang=en-us}.
This paper has not been read by Pith yet.
Forward citations
Cited by 2 Pith papers
-
MedStruct-S: A Benchmark for Key Discovery, Key-Conditioned QA and Semi-Structured Extraction from OCR Clinical Reports
MedStruct-S benchmark shows encoder-only models outperform larger decoder-only ones on key-conditioned QA from noisy OCR clinical reports, with fine-tuned large models winning only when scale is ignored.
-
Real-World Doctor Agent with Proactive Consultation through Multi-Agent Reinforcement Learning
DoctorAgent-RL trains a Qwen2.5-7B doctor agent via multi-agent RL on the new MTMedDialog dataset to conduct dynamic, question-driven consultations, reaching 70% exact diagnostic match in real-patient trials.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.